Webinar: COVID-19 Webinar Updates for HIV Providers: Outpatient Opioid Use Disorder Treatment During COVID-19
Facilitated by
- Michelle Lofwall, MD
(University of Kentucky College of Medicine) - Laura Fanucchi, MD MPH
(University of Kentucky College of Medicine)
March 27, 2020
Other Trainings
Objectives
- Explain the national and state guidance including emergency regulatory changes for outpatient office-based buprenorphine treatment for Opioid Use Disorder given COVID
- Provide resources for staying up-to-date regarding outpatient care for persons with Opioid Use Disorder
- Review guidance on urine testing
- Provide example of changes in practice from University of Kentucky outpatient treatment for OUD
Presentation
Facilitated by
- Michelle Lofwall, MD
(University of Kentucky College of Medicine) - Laura Fanucchi, MD MPH
(University of Kentucky College of Medicine)
March 27, 2020
Objectives
- Explain the national and state guidance including emergency regulatory changes for outpatient office-based buprenorphine treatment for Opioid Use Disorder given COVID
- Provide resources for staying up-to-date regarding outpatient care for persons with Opioid Use Disorder
- Review guidance on urine testing
- Provide example of changes in practice from University of Kentucky outpatient treatment for OUD
Presentation
Other Trainings
Facilitated by
- Michelle Lofwall, MD
(University of Kentucky College of Medicine) - Laura Fanucchi, MD MPH
(University of Kentucky College of Medicine)
March 27, 2020
Objectives
- Explain the national and state guidance including emergency regulatory changes for outpatient office-based buprenorphine treatment for Opioid Use Disorder given COVID
- Provide resources for staying up-to-date regarding outpatient care for persons with Opioid Use Disorder
- Review guidance on urine testing
- Provide example of changes in practice from University of Kentucky outpatient treatment for OUD
